In Q3, Omixon will be launching HLA Explore to replace Target HLA as our primary research use software product for HLA Genotyping by NGS. HLA Explore is designed for genetics/genomics researchers and the analysis and interpretation of any NGS data. It is flexible and customizable to handle all sequencing data types from short read technologies such as Illumina and Ion Torrent, as well as newer long-read technologies from Pacific Biosciences and Oxford Nanopore. HLA Explore can analyze data from any experiment type such as targeted exons, targeted whole genes, whole MHC, whole exome or whole genome. It is a high-performance, high-throughput and high-resolution multi-sample software for genotyping analysis, interpretation and reporting.
- Effective August 1, 2016, Omixon will no longer sell credits for Omixon Target HLA
- Between August 1, 2016 and March 1, 2017, Omixon will assist with data migration from Omixon Target HLA to Omixon HLA Explore (requires re-analysis)
- Effective July 1, 2017, Omixon will no longer support Omixon Target HLA in any form